Biology subjects

Sharpton, T.

Publications and source records attributed to Sharpton, T..

3 recordsLinked to original sources

bioRxiv2020

Testing monotonic trends among multiple group means against a composite null

In biomedical applications, it is often of interest to test the alternative hypothesis that the means of three or more groups follow a strictly monotonic trend such as {micro}1 > {micro}2 > {micro}3 against the null hypothesis that the group means are either equal or unequal but are not monotonic. This is useful, for example, for detecting biomarkers whose level in healthy, low-risk cancer and aggressive cancer subjects increases or decreases throughout the three groups. Various trend tests are available for testing monotonic alternatives. However, existing methods are designed for a highly restrictive null hypothesis where all group means are equal, which represents a special case of the null space in our problem. We demonstrate that these methods fail to control type I error when the group means may be unequal under the null. To test this broader null hypothesis, develop a greedy testing method which has an intuitive interpretation related to two-sample t tests. We show both theoretically and through simulations that the proposed method effectively controls type 1 error throughout the entire null space and achieves higher power than a naive implementation of multiple t-tests. We illustrate the greedy trend test method in real data to study microbial associations with parasite-related pathology in zebrafish.

bioinformatics↗

bioRxiv2019

Gut feelings begin in childhood: how the gut metagenome links to early environment, caregiving, and behavior

Psychosocial environments impact normative behavioral development in children, increasing the risk of problem behaviors and psychiatric disorders across the lifespan. Converging evidence demonstrates early normative development is affected by the gut microbiome, which itself can be altered by early psychosocial environments. Nevertheless, these relationships are poorly understood in childhood, particularly beyond peri- and postnatal microbial colonization. To determine the gut microbiomes role in the associations between childhood adversity and behavioral development, we conducted a metagenomic investigation among cross-sectional sample of early school-aged children with a range of adverse experiences and caregiver stressors and relationships. Our results indicate that the taxonomic and functional composition of the gut microbiome links to behavioral dysregulation during a critical period of child development. Furthermore, our analysis reveals that both socioeconomic risk exposure and child behaviors associate with the relative abundances of specific taxa (e.g., Bacteroides and Bifidobacterium species) as well as functional modules encoded in their genomes (e.g., monoamine metabolism) that have been linked to cognition and health. We also identified heretofore novel linkages between gut microbiota, their functions, and behavior. These findings hold important translational implications for developmental psychology and microbiome sciences alike, as they suggest that caregiver behavior might mitigate the impact of socioeconomic risk on the microbiome and modify the relationship between subclinical symptoms of behavioral dysregulation and the gut microbiome in early school-aged children.

microbiology↗

bioRxiv2017

Development of Inflammatory Bowel Disease is Linked to a Longitudinal Restructuring of the Gut Metagenome in Mice

The gut microbiome is linked to inflammatory bowel disease (IBD) severity and altered in late stage disease. However, it is unclear how gut microbial communities change over the course of IBD development, especially in regards to function. To investigate microbiome mediated disease mechanisms and discover early biomarkers of IBD, we conducted a longitudinal metagenomic investigation in an established mouse model of IBD, where dampened TGF-{beta} signaling in T cells leads to peripheral immune activation, weight loss, and severe colitis. IBD development is associated with abnormal gut microbiome temporal dynamics, including dampened acquisition of functional diversity and significant differences in abundance trajectories for KEGG modules such as glycosaminoglycan degradation, cellular chemotaxis, and type III and IV secretion systems. Most differences between sick and control mice emerge when mice begin to lose weight and heightened T cell activation is detected in peripheral blood. However, lipooligosaccharide transporter abundance diverges prior to immune activation, indicating that it could be a pre-disease indicator or microbiome-mediated disease mechanism. Taxonomic structure of the gut microbiome also significantly changes in association with IBD development, and the abundance of particular taxa, including several species of Bacteroides, correlate with immune activation. These discoveries were enabled by our use of generalized linear mixed effects models to test for differences in longitudinal profiles between healthy and diseased mice while accounting for the distributions of taxon and gene counts in metagenomic data. These findings demonstrate that longitudinal metagenomics is useful for discovering potential mechanisms through which the gut microbiome becomes altered in IBD.\n\nImportanceIBD patients harbor distinct microbial communities with different functional capabilities compared to healthy people. But is this cause or effect? Answering this question requires data on changes in gut microbial communities leading up to disease onset. By performing weekly metagenomic sequencing and mixed effects modeling on an established mouse model of IBD, we identified several functional pathways encoded by the gut microbiome that covary with host immune status. These pathways are novel early biomarkers that may either enable microbes to live inside an inflamed gut or contribute to immune activation in IBD mice. Future work will validate the potential roles of these microbial pathways in host-microbe interactions and human disease. This study is novel in its longitudinal design and focus on microbial pathways, which provided new mechanistic insights into the role of gut microbes in IBD development.

microbiology↗